SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) today announced receipt of Shonin approval from the Ministry of Health, Labour and Welfare (MHLW) to market in Japan its full line of stretch-resistant microcoils for the endovascular treatment of cerebral aneurysms, including the Cashmere™, Presidio®, HeliPaq® and UltiPaq® stretch-resistant embolic coils. Sales of Micrus stretch-resistant microcoils will be managed by Goodman Co., Ltd., Micrus Endovascular’s exclusive distributor in the Japanese market.
